2007
DOI: 10.1016/j.bbrc.2007.05.095
|View full text |Cite
|
Sign up to set email alerts
|

Role of cardiovascular nitric oxide system in C-type natriuretic peptide effects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
18
0
2

Year Published

2011
2011
2019
2019

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 24 publications
(27 citation statements)
references
References 29 publications
7
18
0
2
Order By: Relevance
“…In addition, in our previous studies we showed that the peptide also increases endothelial NO synthase (eNOS) activity through NPR-C-coupled Gi protein activation in aorta of spontaneously hypertensive rats (SHR). The response of the NO system to CNP is lower in hypertensive than in normotensive rats [6,7]. It is well documented that endothelial production of NO causes vasorelaxation primarily by activating soluble guanylyl cyclase (sGC) in smooth muscle cells and by increasing intracellular cGMP, which in turn activates protein kinase G to induce vasorelaxation by decreasing cytosolic Ca 2+ concentration [8,9].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, in our previous studies we showed that the peptide also increases endothelial NO synthase (eNOS) activity through NPR-C-coupled Gi protein activation in aorta of spontaneously hypertensive rats (SHR). The response of the NO system to CNP is lower in hypertensive than in normotensive rats [6,7]. It is well documented that endothelial production of NO causes vasorelaxation primarily by activating soluble guanylyl cyclase (sGC) in smooth muscle cells and by increasing intracellular cGMP, which in turn activates protein kinase G to induce vasorelaxation by decreasing cytosolic Ca 2+ concentration [8,9].…”
Section: Introductionmentioning
confidence: 99%
“…A third natriuretic receptor subtype, NPR-C, has been proposed primarily as a clearance receptor removing natriuretic peptides from the circulation, but now other biological functions have also been reported (2,4,5). In this regard, NPR-C is coupled to adenylyl cyclase through an inhibitory guanine nucleotide-regulatory protein (G i ) and/or to activation of phospholipase C (PLC) (2,30).…”
mentioning
confidence: 98%
“…[3,14] Moreover, CNP also shows anti-atherogenic properties on vessel walls with the inhibition of leukocyte migration and suppression of P-selectin expression. [14,15] Furthermore, Costa et al [16] demonstrated that infusion of CNP increases inducible nitric oxide synthase (iNOS) expression. Interestingly, some researchers have also claimed that CNP has a vaso-relaxant impact through the increased production of endothelial NO via elevated iNOS activity.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, some researchers have also claimed that CNP has a vaso-relaxant impact through the increased production of endothelial NO via elevated iNOS activity. [16,17] Several studies have investigated NPR-B as it relates to inducible ischemia types. [5,18] Staub et al [5] suggested that it might have diagnostic value in the determination of inducible myocardial ischemia, and Kumakura et al [7] reported that high NPR-B levels correlated with a number of affected distal arteries in critical limb ischemia.…”
Section: Discussionmentioning
confidence: 99%